Understanding effectual decision-making in a science-based business: The case of Hart Biologicals

Steven Pattinson*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

8 Citations (Scopus)
27 Downloads (Pure)


This case focuses on the effectual decision-making processes of an individual entrepreneur. It examines a proposed acquisition by Hart Biologicals, a small biotechnology company based in the Northeast England. Alby Pattison, the
Managing Director, is currently considering an acquisition with a ‘symbiotic’ business. The firm is working in the same area as Hart Biologicals (haematology) but is not a competitor. Alby considers that the acquisition would help the
company grow more rapidly and add to its current portfolio of products. The case considers how effectual decision making is employed by the entrepreneur to identify, evaluate and pursue new opportunities. This concept is explored in
the context of the current dilemma of Hart Biologicals proposed acquisition. Finally, the case also considers the impact of the acquisition on the performance and behaviour of a family firm.
Original languageEnglish
Pages (from-to)65-71
Number of pages7
JournalInternational Journal of Entrepreneurship and Innovation
Issue number1
Early online date10 Dec 2018
Publication statusPublished - 1 Feb 2019


Dive into the research topics of 'Understanding effectual decision-making in a science-based business: The case of Hart Biologicals'. Together they form a unique fingerprint.

Cite this